Lidwine W Tick

8PUBLICATIONS
80CO-AUTHORS
Tumour immunologyHaematological tumoursStatistical theoryMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 04, 2026
Treatment Patterns, Outcomes and Survival Trends in T-Cell Prolymphocytic Leukemia: A Nationwide Population-Based Study in the Netherlands.

|Sep 04, 2024
Risk Stratification in Older Intensively Treated Patients With AML.

Jurjen Versluis, Marlen Metzner, Ariel Wang

|Aug 19, 2024
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients.

Monique C Minnema, Kazem Nasserinejad, Ute Hegenbart

|Oct 31, 2022
Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.

Tim Grob, Mathijs A Sanders, Christian M Vonk

|Jul 22, 2022
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

J J W M Janssen, B Löwenberg, M Manz

|Mar 08, 2022
Comparing Survivors of Cancer in Population-Based Samples With Those in Online Cancer Communities: Cross-sectional Questionnaire Study.

Mies C van Eenbergen, Ruben D Vromans, Lidwine W Tick

Pageof 2

Frequent Collaborators

3 joint publications

Markus Manz

2 joint publications

Bob Löwenberg

2 joint publications

Marie Jose Kersten

2 joint publications

Kazem Nasserinejad